Join
Live feed
·
PRReleasevia Quantisnow
Blackstone Inc. logo

Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront

ByQuantisnow·Wall Street's wire, on your screen.
BX· Blackstone Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BX (Blackstone Inc.) and more on Quantisnow.